Wednesday, May 26, 2021 3:03:20 PM
It’s not my theory. Jeez.
Anyway, they did “say something.” They said a rumor was important enough to make it item two of an annual shareholders meeting discussion.
You seem to think it’s not strange she did this. It is strange, on different levels.
1. There are rumors about ASCO every year. What’s so special about this year?
2. NWBO puts in shell abstracts at conferences like popcorn, and then withdraws them like popcorn. They’ve kind of desensitized everyone.
3. To my knowledge, there was low expectation of ASCO presentation on phase III results before LP quashed the supposed rumor.
4. There seemed to be a disconnect between LP’s concern and the nonplussed sentiment of outsiders. What’s new?
5. The people that live for ASCO bubbles in PPS were downtrodden after her pre-ASCO bubble burst.
Anyway, they did “say something.” They said a rumor was important enough to make it item two of an annual shareholders meeting discussion.
You seem to think it’s not strange she did this. It is strange, on different levels.
1. There are rumors about ASCO every year. What’s so special about this year?
2. NWBO puts in shell abstracts at conferences like popcorn, and then withdraws them like popcorn. They’ve kind of desensitized everyone.
3. To my knowledge, there was low expectation of ASCO presentation on phase III results before LP quashed the supposed rumor.
4. There seemed to be a disconnect between LP’s concern and the nonplussed sentiment of outsiders. What’s new?
5. The people that live for ASCO bubbles in PPS were downtrodden after her pre-ASCO bubble burst.
WEAR A MASK.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
